Liverpool/New Delhi: Thousands of delegates from across Britain and the world visited the Liverpool city region for the International Business Festival in June.
The bioConclave was one of the major events on the life sciences day, focusing on patient centricity, data, and technology.
The event discussions featured best practices and case studies on successful patient engagement, recruitment techniques using novel, patient-centric and data-driven approaches. It looked at how technology and data are at the forefront driving clinical trial decision making globally. With further advancements in new technologies (such as mobile devices and wearables) and the rise of online communities, how the pharma and biotech industries are poised to capitalise on these advancements to innovate existing clinical trial processes and systems.
Speakers included Urvashi Prasad, from the Office of Vice Chairman, NITI Aayog in the Government of India, Professor S.S. Vasan from Public Health England as well as the co-founders of several innovative initiatives in digital health and patient recruitment.
Petra Jantzer, Managing Director for the life sciences division at Accenture talked about how the world of healthcare had changed, with disruption occurring in socio-economic terms through an ageing population and the rise in chronic diseases, in science, as well through increasing digitisation and business model disruption.
Andrew Fried, Global Industry Leader for life sciences at IBM echoed this, saying “Global forces are disrupting the status quo which is escalating healthcare’s sustainability crisis.”.
